PECAM1 and neoplasm: The inhibitory effect of XYS was accompanied by downregulated expression of TGF-β, IL-6, MMP-9 and VEGF in spleen tumours, as well as suppression of VEGF and CD31 proteins in hepatic metastatic tissue.